Who Owns Everest Re Stock?

This afternoon we watched Everest Re drop -2.0% to a price of $337.56 per share. The mid-cap Reinsurance company is now trading -13.04% below its average target price of $388.17. Analysts have set target prices ranging from $358 to $419 per share for Everest Re, and have given the stock an average rating of buy.

The stock has a very low short interest at 1.5%, and a short ratio of 1.49. The company's insiders own 1.57% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 96.6% of Everest Re's shares being owned by this investor type.

Institutions Invested in Everest Re

Holder Shares Date Reported Percentage Value
Vanguard Group, Inc. (The) 4,906,545 2022-09-29 13% $1,656,277,874
Blackrock Inc. 2,811,152 2022-09-29 7% $948,946,531
Boston Partners 2,587,523 2022-09-29 7% $873,457,207
State Street Corporation 1,883,542 2022-09-29 5% $635,817,859
Franklin Resources, Inc. 1,740,954 2022-09-29 4% $587,685,141
Champlain Investment Partners, LLC 1,238,860 2022-09-29 3% $418,195,778
Victory Capital Management Inc. 1,188,259 2022-09-29 3% $401,114,652
Massachusetts Financial Services Co. 1,063,314 2022-09-29 3% $358,937,593
Altrinsic Global Advisors, LLC 846,516 2022-09-29 2% $285,754,175
Geode Capital Management, LLC 808,862 2022-09-29 2% $273,043,503

Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Everest Re.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.